tirzepatide type of drug enhances weight loss with sustained treatment but discontinuation leads to weight regain Tirzepatide, the active ingredient behind

The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus

Additionally, LY3298176 led to weight loss, with a higher proportion of patients achieving the weight loss targets compared to dulaglutide and the placebo

R.SixA.et al (2019)

Your healthcare provider or dietitian can help you devise an appropriate meal plan and exercise regimen

Data shows that 75% of mild symptoms resolve once you reach a stable maintenance dose

In the third Group, teneligliptin and sitagliptin interact with the extended S2 subsite of the DPP-4 active site and exhibit the highest inhibitory function against DPP-4 [113]